|
Volume 272, Number 26,
Issue of June 27, 1997
pp. 16431-16437
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Identification and Characterization of Multiple Osmotic Response
Sequences in the Human Aldose Reductase Gene*
(Received for publication, October 7, 1996, and in revised form, January 24, 1997)
Ben C. B.
Ko
,
Barbara
Ruepp
§,
Kurt M.
Bohren
§,
Kenneth H.
Gabbay
§ and
Stephen S. M.
Chung
¶
From the Institute of Molecular Biology, The
University of Hong Kong, 3/F, 8 Sassoon Road, Pokfulam, Hong Kong
and the § Molecular Diabetes and Metabolism Section,
Departments of Pediatrics and Cell Biology, Baylor College of
Medicine, Houston, Texas 77030
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Aldose reductase (AR) has been implicated in
osmoregulation in the kidney because it reduces glucose to sorbitol,
which can serve as an osmolite. Under hyperosmotic stress,
transcription of this gene is induced to increase the enzyme level.
This mode of osmotic regulation of AR gene expression has been observed in a number of nonrenal cells as well, suggesting that this is a common
response to hyperosmotic stress. We have identified a 132-base pair
sequence ~1 kilobase pairs upstream of the transcription start site
of the AR gene that enhances the transcription activity of the AR
promoter as well as that of the SV40 promoter when the cells are under
hyperosmotic stress. Within this 132-base pair sequence, there are
three sequences that resemble TonE, the tonicity response element of
the canine betaine transporter gene, and the osmotic response element
of the rabbit AR gene, suggesting that the mechanism of osmotic
regulation of gene expression in these animals is similar. However, our
data indicate that cooperative interaction among the three TonE-like
sequences in the human AR may be necessary for their enhancer
function.
INTRODUCTION
Mammalian kidneys are constantly exposed to steep osmotic
gradients because of the urine-concentrating mechanism. However, kidney
cells, especially the epithelial cells lining the inner renal medulla,
are protected from the osmotic effect of concentrated sodium ion and
urea in the interstitium by accumulating organic osmolytes such as
sorbitol, betaine, inositol, glycerophosphocholine, and taurine (1).
These organic osmolytes are involved in maintaining cell volume and
electrolyte contents without perturbing the protein structure and
function over a wide range of concentrations (2).
Sorbitol is one of the principal organic osmolytes in the inner medulla
(3, 4). It is produced via the reduction of D-glucose by
the enzyme aldose reductase (AR1; EC
1.1.1.21). AR is present in a variety of tissues including kidney (5),
liver (6), ocular lens, and retina (7) and in erythrocytes (8).
Although AR has been implicated in the pathogenesis of various diabetic
complications such as diabetic cataracts, retinopathy, and neuropathy
(9-11), the physiological role of this enzyme is still unclear, except
that in the renal medulla, it produces sorbitol to serve as an
osmoprotectant (12), and in the testis, in conjunction with sorbitol
dehydrogenase, it synthesizes fructose, the major energy source for
sperm (13).
The expression of the AR gene in the renal medulla of mammals has been
shown to be osmotically regulated. In this tissue, AR mRNA and
sorbitol content increase during dehydration or antidiuresis and
decrease during diuresis (14). Moreover, experiments on PAP-H25 cells
derived from rabbit renal papillae demonstrated that external
hyperosmolality enhances transcription of the AR gene (15), resulting
in a rapid increase in AR mRNA (16), followed by an increase in AR
activity and sorbitol content (17).
In mammals, several genes other than aldose reductase are known to be
regulated by osmolality. They include the myo-inositol, betaine, and taurine transporters (18). However, how the initial signal
of external hyperosmolality is relayed to the nucleus to induce the
expression of these genes is still unknown. Recently, the sequence of
the putative osmotic response element of the canine betaine transporter
gene, TonE, was described (19), providing a starting point to
understand this interesting mode of gene regulation. In addition, while
we were preparing this report, the 11-bp osmotic response element (ORE)
essential for osmoregulation of the rabbit AR gene was reported and
found to be located 1105 bp upstream of the transcription start site
(20). Recently, we identified a putative functional ORE found to be
located 3.7 kb upstream of the transcription start site of the aldose
reductase gene (21). We hereby show that this putative AR ORE resulted
from a cloning artifact occurring at 1066 bp (MboI
restriction site) upstream of the initiation transcription site in a
human aldose reductase gene isolated from a commercially obtained
genomic library constructed by partial digestion with MboI
restriction enzyme.
In this study, we have identified an osmotic response region of the
human AR gene within a 132-bp region located 1235 bp upstream of the
transcription start site of human AR gene. Within this region, there
are three sequences homologous to TonE of the canine betaine
transporter gene and to the ORE of the rabbit AR gene. The osmotic
response function is reduced when any one of these three sequences is
mutated, suggesting that these sequences have to work in concert to
provide maximum transcription induction.
MATERIALS AND METHODS
Cell Cultures
Chang liver cells (American Type Culture
Collection) were maintained in isosmotic growth medium (Eagle's basal
medium supplemented with 10% calf serum and 2 mM
L-glutamine; 300 mosmol/kg of H2O) at
37 °C in the presence of 5% CO2. To investigate the
osmotic induction of AR mRNA, these cells (3 × 106) were seeded onto 100-mm culture dishes and incubated
in fresh isosmotic growth medium for 24 h. The medium were
removed, and the cells were incubated in either isosmotic or
hyperosmotic growth medium (isosmotic medium supplemented with 5 M NaCl to final concentrations of 50 mM ( 380
mosmol/kg of H2O) and 100 mM ( 500 mosmol/kg
of H2O)).
Isolation of Total RNA
A total of 1 × 107
cells were used to extract RNA in each experiment. Total RNA was
extracted by a modification of the protocol of Auffray and Rougeon
(22). Chang liver cells on culture dishes were washed twice
with ice-cold phosphate-buffered saline; scraped off the dishes; and
then transferred into tubes containing 1.5 ml of 3 M LiCl
and 6 M urea solution. These cells were kept on ice, mixed,
and homogenized by a Polytron homogenizer (Kinematic, Lucerne,
Switzerland) for 1-2 min with a 30-s interval. The homogenate was kept
on ice overnight. Total RNA was pelleted by centrifugation at
15,000 × g for 30 min at 4 °C. Pellets were washed
twice with the 3 M LiCl and 6 M urea solution,
drained, and resuspended in 0.4 ml of Tris/EDTA buffer containing 0.5%
SDS and 200 µg of proteinase K. The resuspensions were incubated at
37 °C for 30-60 min. RNA was extracted twice with phenol/chloroform
(1:1, v/v) and once with chloroform/isoamyl alcohol (24:1, v/v) and
precipitated with 0.1 volume of 3 M sodium acetate and 2.5 volumes of absolute ethanol at 20 °C for 2 h. The mixtures
were centrifuged for 20 min at 15,000 × g at 4 °C.
The RNA was washed in 70% ethanol and resuspended in Tris/EDTA buffer.
The concentration of RNA was determined by measuring the absorbance at
260 nm.
Northern Blot Hybridization
20 µg of each total
RNA sample from Chang liver cells was loaded on 1.2% agarose gel
containing 3% formaldehyde. After electrophoresis, the RNA was
transferred onto Hybond-N+ membrane (Amersham
International, Buckinghamshire, United Kingdom) by capillary blotting
in 20 × SSC. The membrane was first incubated with
prehybridization buffer (7% SDS and 0.25 M sodium
phosphate) at 65 °C for 1 h and then with hybridization buffer
containing [ -32P]dCTP-labeled human AR cDNA probe
and incubated at 65 °C for 12 h. The AR cDNA probe (23) was
isolated from a Bluescript subclone and labeled by random priming of
DNA polymerase (Megaprime kit, Amersham International) to a specific
activity of 1-2 × 109 cpm/µg. After hybridization,
the filter was washed with 0.1 × SSC and 0.5% SDS at 65 °C
for 1 h and exposed to X-Omat AR film (Eastman Kodak Co.) at
70 °C with intensifying screens. The filter was then stripped in
0.1 × SSC and 0.5% SDS at 100 °C and rehybridized to an
[ -32P]dCTP-labeled human -actin cDNA (CLONTECH,
Palo Alto, CA).
Genomic Cloning
To obtain the promoter sequence
of AR, a human genomic DNA library in FIXII vector (Stratagene, La
Jolla, CA) was screened using two [ -32P]ATP
5 -end-labeled oligonucleotide primers derived from the genomic clone
we described before (24): ARpr1, 5 -GAATCTTAACATGCTCTGAACC-3 ; and
ARpr2, 5 -GCCCAGCCCTATACCTAGT-3 . Both primers are located 2.1 kb
upstream of the transcription start site of the AR gene. An
[ -32P]dCTP-labeled AR cDNA was used as a
hybridization probe in the secondary screening.
Southern Blot Analysis of AR 5 -Flanking Region
Southern
blot hybridization using different probes was used to confirm the
identity of the genomic clone AR5. As shown in Fig. 2A,
probe S spans from 1536 to 1174 of AR5; probe Co spans from 1099
to 468, which is common to both AR5 and the AR gene of Ruepp et
al. (21); and probe G spans from 3339 to 2765 of the AR gene
identified by Ruepp et al. (21). Probe G was prepared by
polymerase chain reaction using a pair of amplification primers, Prpr1
( 3339 to 3320, 5 -ATGCAACTAGAGTGTCCACC-3 ) and Prpr2 ( 2765 to
2785, 5 -AGGTTCTACTGGTTCTACTAC-3 ). The polymerase chain reaction
product was cloned into a plasmid vector and verified by DNA sequence
determination. Caucasian and Chinese DNAs were digested with
KpnI, HindIII, and EcoRV restriction
enzymes and hybridized to radioactively labeled probes S, Co, and G,
respectively, in a Southern blot.
Fig. 2.
Southern blot hybridization with the AR5 and
6A3a probes. A, the structures of clones AR5 and 6A3a are
schematically shown. The asterisk indicates position 1066,
upstream of which the sequences of the two clones are different. Probe
Co ( 1099 to 468) is common to both clones. Probe S is from 1535
to 1174 of AR5, and probe G is from 3339 to 2765 of 6A3a.
B, in each panel, lanes 1 and 2 contain DNA from a Caucasian, and lanes 3 and 4 contain DNA from a Chinese. DNAs in lanes 1 and 3 were digested with HindIII and KpnI, and DNAs in
lanes 2 and 4 were digested with EcoRV
and KpnI. Lane M contains a 1-kb molecular size
marker with one band hybridized to 1.6 kb and serves as a point of
reference. Probes Co and S hybridized to identical bands of expected
size, indicating that the sequences represented by these two probes are
contiguous in the genome. Probe G hybridized to bands different from
those of probe Co, and the sizes of these bands are different from
those predicted from the sequence of 6A3a, indicating that clone 6A3a
is probably made up of two disjoined fragments.
[View Larger Version of this Image (49K GIF file)]
Plasmid Construction
Two luciferase reporter vectors
(pGL3), one controlled by the SV40 promoter (SVLuc) and the other being
promoterless (BLuc), were purchased from Promega (Madison, WI).
-Galactosidase reporter vector controlled by the adenovirus promoter
(ADGal) was purchased from CLONTECH. The various reporter constructs
are shown schematically in Fig. 3. 2.8AR.BLuc was constructed by
subcloning a 2.8-kb fragment of AR 5 -flanking sequence, which spans
from 2733 to +41, into the unique HindIII-NcoI
site immediately upstream of the luciferase gene of BLuc. A series of
progressively shorter AR constructs, namely Del1.BLuc, Del2.BLuc,
Del3.BLuc, Del4.BLuc, Del4.1.BLuc, and Del5.BLuc, was made by
restriction digestion of 2.8AR.BLuc with SacI and
HindIII in the multiple cloning site on the backbone of
BLuc, followed by a unidirectional nested deletion in the 2.8-kb human
AR 5 -flanking region of 2.8AR.BLuc using the exonuclease III/mung bean
nuclease deletion kit (Stratagene). The lengths of different deletions
were determined by DNA sequence analysis and are indicated in Fig. 3.
To confirm the location of the osmotic response region, p132-SVLuc was
made by inserting a 132-bp fragment (from 1235 to 1104) into the
KpnI-SmaI site immediately upstream of the SV40
promoter of SVLuc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fig. 3.
Localization of ORE. A schematic diagram
of AR5 is presented at the top. The bent arrow represents
the transcription start site of the AR gene. Fragments of the AR
5 -flanking region of different length were fused to the luciferase
gene, introduced into Chang liver cells, and maintained in isosmotic
(I) or hyperosmotic (H) medium. After 12 h,
the cells were harvested, and the luciferase and -galactosidase
activities were determined as described under "Materials and
Methods." The numbers shown are the ratio of relative light units of
luciferase activity to -galactosidase activity. Values are the
means ± S.D. of three independent transfections. H/I
represents the induction of reporter gene activity by hyperosmotic stress.
[View Larger Version of this Image (13K GIF file)]
To better understand if there is more than one putative osmotic
response element within the 132-bp fragment, six double-stranded oligonucleotides were made and then engineered to form different reporter constructs as described below (nucleotides that differ from
the wild-type sequence are in boldface).
pAB-SVLuc was constructed by cloning fragment AB into the
KpnI-MluI site upstream of the SV40 promoter of
SVLuc, pC-SVLuc by inserting fragment C into the
MluI-XhoI site of the SV40 promoter of SVLuc,
pABC-SVLuc by inserting fragment C into the
MluI-XhoI site of pAB-SVLuc, and pABCD-SVLuc by
inserting fragment D into the BglII site of pABC-SVLuc.
pABmCD-SVLuc was constructed by inserting fragment mC into the
MluI-XhoI site and fragment D into BglII site of pAB-SVLuc, respectively; and pmABCD-SVLuc and
pAmBCD-SVLuc were constructed by inserting fragments mAB and AmB into
the KpnI-MluI site of SVLuc, respectively,
followed by inserting fragment C into the
MluI-XhoI site and fragment D into the
BglII site of SVLuc. The sequences of all the constructs
were verified by DNA sequence determination.
DNA Sequencing
The sequence of the 5 -flanking region of
AR5 was obtained by sequencing the clones generated by nested
deletions. Sequencing was performed using the fmolTM DNA
sequencing system purchased from Promega and later using the ABI prism
dye terminator cycle sequencing ready reaction kit purchased from
Perkin-Elmer.
DNA Transfection and Luciferase, -Galactosidase, and Protein
Assays
Plasmid DNAs were purified as described (25) with CsCl
ultracentrifugation steps. The promoter activities of various
constructs were determined in transiently transfected Chang liver
cells. In each transfection experiment, Chang liver cells were seeded into six 60-mm culture dishes (6 × 105 cells/dish)
and incubated for 24 h in isosmotic medium before transfection.
Cells were then cotransfected with 2 µg of luciferase reporter
construct and 1 µg of -galactosidase reporter construct using
Tfx-50 reagent (Promega) in serum-free medium. After incubation for
1 h at 37 °C, the medium was removed, and the cells were
incubated in fresh isosmotic medium ( 300 mosmol/kg of
H2O) for 12 h. A set of three dishes was changed to
fresh isosmotic medium, while the other set was changed to fresh
hyperosmotic medium (100 mM NaCl; 500 mosmol/kg of
H2O). After incubation for 12 h, the cells were
harvested after washing with phosphate-buffered saline and adding 400 µl of lysis buffer (Promega).
Luciferase activity expressed as relative light units was assayed by
mixing 10-20 µl of cell extracts with luciferase assay reagent
(Promega) according to manufacturer's protocol, and the light emitted
was measured by a Lumat LB 9507 luminometer (EG&G Berthold, Berlin,
Germany). -Galactosidase activity was measured in the same way,
except that the cell extracts were assayed with reaction buffer
containing chemiluminescent substrate (Tropix Inc., Bedford, MA). Total
cell protein was determined with a Bio-Rad protein assay kit using
-globulin as the standard. Pilot studies showed that the amount of
cell extract used falls within the linear range of luciferase and
-galactosidase assays.
In each transfection experiment, the luciferase activity in relative
light units/µg of total cell protein was normalized by -galactosidase activity in relative light units/µg of total cell protein. A minimum of three independent transfections were done for
each construct. Results are expressed as means ± S.D.
Preparation of Nuclear Extract
Chang liver cells (1 × 107) were initially grown in isosmotic medium ( 300
mosmol/kg of H2O) in 100-mm tissue culture dishes. The
medium was replaced by either fresh isosmotic or hyperosmotic medium
(100 mM NaCl; 500 mosmol/kg of H2O) for
another 24 h. The cells were washed and scraped into 5 ml of cold
phosphate-buffered saline and centrifuged for 1 min at 4 °C, and the
pellet was resuspended in 1 ml of cold Buffer A (10 mM
HEPES-KOH, pH 7.9, at 4 °C, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride). The cells were again
pelleted and resuspended in 45 µl of Buffer A with 0.05% Nonidet
P-40. Samples were incubated for 5 min and centrifuged for 10 min. The
supernatant fraction was discarded, and the pellet was resuspended in
10 µl of cold Buffer C (20 mM HEPES-KOH, pH 7.9, 25%
glycerol, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM
dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride)
and incubated for 15 min. After vortexing, the cellular debris was
removed by centrifugation for 10 min at 4 °C, and the supernatant
fraction containing the DNA-binding proteins was diluted with 60 µl
of modified Buffer D (20 mM HEPES, pH 7.9, 0.05 M KCl, 0.2 mM EDTA, 0.5 mM
dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, and
20% glycerol), divided into aliquots, and stored at 70 °C.
Protein concentration was determined by the Bio-Rad protein assay kit
using -globulin as the standard.
Gel Mobility Shift Assay
The 132-bp fragment ( 1235 to
1104) containing the osmotic response region was released from
p132-SVLuc by digestion with the restriction enzymes KpnI
and XhoI. The resulting fragment was then labeled with
[ -32P]dCTP using Klenow fragment. Nuclear extracts
(1-4 µg) were incubated with 20,000 cpm of 32P-labeled
132-bp probe in 20 µl of binding reaction mixture containing 12 mM HEPES-KOH, pH 7.9, 60 mM KCl, 5 mM MgCl2, 0.12 mM EDTA, 0.3 mM phenylmethylsulfonyl fluoride, 0.3 mM
dithiothreitol, 2 µg of poly(dI·dC), and 1 µg of pGEM-7zft
(Promega). After incubation at room temperature for 10 min, the mixture
was electrophoresed on a 4% polyacrylamide gel (79:1
acrylamide/bisacrylamide) in 45 mM Tris borate, 45 mM boric acid, and 2 mM EDTA at 4 °C. The gel was then dried and exposed for 1-2 days at 70 °C with
intensifying screens. For competition experiments, 10- and 50-fold
molar excesses of unlabeled 132-bp fragment were added to the reaction
mixture prior to the addition of radiolabeled probe.
RESULTS
Induction of AR mRNA by Hyperosmolality
Hyperosmolality
has been shown to induce the expression of the AR gene in a number of
cell lines tested in addition to renal cell lines (26-28). We found
that Chang liver cells, a human liver cell line, also induce AR
expression in response to hyperosmotic stress. Fig.
1 shows the time- and osmolality-dependent
changes in AR mRNA in Chang liver cells following exposure to
medium supplemented with either 50 mM ( 380 mosmol/kg of
H2O) or 100 mM ( 500 mosmol/kg of
H2O) NaCl. Control cells showed a relatively constant level of AR mRNA throughout the time course of 36 h. In cells
maintained in hyperosmotic medium, there was an induction of AR
mRNA expression within 12 h, reaching a maximum within 24 h and remaining at steady state at 36 h. After 24 h, there
was a 30-fold induction of AR mRNA in cells maintained in
hyperosmotic medium. The maximum hyperosmotic induction was higher in
100 mM NaCl-treated cells than in 50 mM NaCl-treated cells despite a slight decrease of -actin mRNA
expression in 100 mM NaCl-treated cells. The above results
suggest that the expression of the AR gene in Chang liver cells is
regulated by high salt level in the medium; hence, this cell line was
used as a host to identify the cis-acting element(s) in the
AR gene involved in osmotic regulation of transcription.
Fig. 1.
Induction of aldose reductase gene expression
by hyperosmolality. Chang liver cells were incubated in isosmotic
(Control) or hyperosmotic medium. Hyperosmolality was
achieved by adding NaCl to the final concentration of 50 or 100 mM. Cells were harvested after 12, 24, and 36 h, and
RNA was extracted for Northern blot analysis as described under
"Materials and Methods."
[View Larger Version of this Image (50K GIF file)]
Cloning and Confirmation of Human AR 5 -Flanking Region
We
have previously obtained a human AR genomic DNA clone (1K8) containing
sequence up to 2.7 kb upstream of the transcription start site (24). In
order not to miss the regulatory sequence farther upstream, we set
forth to clone larger fragments of the upstream sequence. Six clones
were isolated from primary screening of the human genomic library using
oligonucleotides deduced from the 1K8 sequence (see "Materials and
Methods") as probes. Two clones were confirmed to contain the AR gene
using AR cDNA as a probe in the secondary screening and by
comparing part of their sequences with published data (29, 30). One of
the two clones (AR5) was found to span 15 to +4 kb relative to the
transcription start site of the AR gene. Preliminary experiments showed
that a putative ORE is located within a 2.8-kb fragment containing the
transcription start site and 41 bp of exon 1 (see below). The sequence
of this fragment and exon 1 and 513 bp of intron 1 sequence from AR5
were determined and deposited in the GenBankTM/EMBL Data Bank. The
sequence from positions 650 to +617 is identical to the available
published sequence with the exception of 8 bp (30), indicating that the
2.8-kb fragment contains the region upstream of the AR gene, and it is
unlikely that it is part of an AR pseudogene. A discrepancy became
apparent between this region and a corresponding region of a putative
aldose reductase gene promoter containing a functional ORE (clone 6A3a)
located ~3.7 kb upstream of the transcription start site (21). The
sequence of this 5 -flanking upstream region was found to be entirely
different from that of AR5 upstream of position 1066 (an
MboI site), whereas the sequences downstream of that
position are identical in the two clones. This suggested that either
AR5 or 6A3a consists of two disjoined fragments linked together during
cloning. This was tested by Southern blot hybridization, and the
results, shown in Fig. 2, indicate that the 2.8-kb
fragment within AR5 is contiguous in the genome, while clone 6A3a
probably consists of part of the AR gene linked to a fragment from a
different part of the genome. This artifact occurred during the
construction of the partially digested MboI human genomic
library (21), CLONTECH.
To locate the ORE of the human AR gene, the 2.8-kb fragment of the
genomic clone AR5 containing 2694 to +41 of the AR gene was fused to
the luciferase reporter gene (2.8AR.BLuc) and transfected into Chang
liver cells. The -galactosidase reporter gene under the control of
the adenovirus promoter was included in every transfection to monitor
the efficiency of transfection. Twelve hours after transfection, cells
were switched to either isosmotic or hyperosmotic medium. After 12 h of incubation in these media, cells were harvested for luciferase and
-galactosidase activity assays as described under "Materials and
Methods." As shown in Fig. 3, transfected cells
incubated in hyperosmotic medium have 12.5-fold higher luciferase activity than those incubated in isosmotic medium, suggesting that the
2.8-kb fragment contains an ORE as previously shown for the rabbit
aldose reductase gene (31). Inclusion of a 5-kb upstream fragment did
not affect the osmotically induced transcription activity (data not
shown), and this fragment was not analyzed further.
The location of the ORE within the 2.8-kb fragment was further
delimited by 5 to 3 nested deletions and testing the shortened fragments in transient transfection assays as described earlier. The
results are summarized in Fig. 3. Deletions from 2694 to 1900 did
not appreciably affect the osmotically induced activity of the reporter
gene. There was a slight drop in osmotic inducible activity when the
sequence was shortened from 1900 to 1500 and another minor drop
when shortened to 1235. The AR 5 -flanking sequences deleted to
1235 can still be induced by hyperosmotic medium by 7.6-fold over
those in isosmotic medium. Further deletion to 1104 totally
obliterated the osmotic response. These results indicate that the major
ORE is located in the 132-bp sequence between 1235 and 1104 and
that there may be an auxiliary ORE between 1900 and 1235 that is
required for full osmotic response.
Characterization of Osmotic Response Region
To test if the
132-bp sequence alone is sufficient to direct osmotically induced
transcription and to test if this sequence can enhance transcription of
the heterologous promoter, it was fused to the SV40 promoter-driven
luciferase reporter gene and transfected in Chang liver cells as
described above. Hyperosmotic medium induced the luciferase activity of
this construct (called p132-SVLuc) to a 10-fold higher level compared
with that in isosmotic medium (Fig. 4B),
indicating that the osmotic response region within the 132-bp fragment
is able to enhance the transcription of the heterologous promoter.
Fig. 4.
Characterization of the osmotic response
region of the AR gene. A, nucleotide sequence of the 132-bp
fragment containing the three TonE-like sequences. OreA, OreB, and OreC
are in boldface and are indicated by A,
B, and C, respectively. The AP-1 consensus sequence is in boldface and is indicated by D.
Portions of this sequence (fragments AB, C, and D as indicated by the
boxes) were fused to the SVLuc reporter gene for
transfection assays. B, AB, C, and
D are fragments of the 132-bp sequence. Construction of these sequences is described under "Materials and Methods."
mA, mB, and mC indicate the mutated
forms of OreA, OreB, and OreC, respectively. Reporter gene assays were
similar to those described in the legend to Fig. 3. H/I
represents the induction of reporter gene activity by hyperosmotic
stress.
[View Larger Version of this Image (34K GIF file)]
Analysis of the 132-bp fragment revealed three sequences that resemble
part of TonE (TGGAAAAGTCCA) of the canine betaine transporter gene (19)
and the ORE (CGGAAAATCAC) of the rabbit AR gene (20) (Fig.
4A). OreA (TGGAAAAATAT, 1230 to 1220) and OreC
(TGGAAAATCA, 1157 to 1148) are in the same orientation as TonE.
OreB (TGGAAAAATTT, 1188 to 1198), on the other hand, is in the
opposite orientation. Sequence D ( 1117 to 1111), highly homologous
to the AP-1 consensus sequence, is located adjacent to these sequences.
It is noteworthy that an AP-1 consensus sequence was also identified at
the 3 -end of the betaine tonicity element. To further examine if all
three TonE-like sequences and the AP-1-like sequence within the 132-bp fragment are involved in osmotic regulation of transcription, we cloned
these sequences into the SVLuc vector and tested them in transfection
assays as indicated in Fig. 4B. Fragment AB contained OreA
and OreB, fragment C contained OreC, and fragment D contained the AP-1
sequence. Assessment of the ability of these fragments to respond to
hyperosmotic induction in transfected cells was performed as described
above. The induction ratio (luciferase activity in hyperosmotic
medium/luciferase activity in isosmotic medium) of fragments AB, C, and
D linked together was 4.9, while that of fragments AB and C was 4.0, indicating that the AP-1-like sequence does not play an important role
in the osmoregulation of AR gene transcription. When base changes were
introduced into OreA, changing the core sequence from
TGGAAAA to TTTCGAA in the pmABCD-SVLuc
construct, the induction ratio dropped to 2.4, suggesting that OreA is
required for full osmotic response. Similarly, when mutations were
introduced into OreB, changing the core sequence from
TGGAAAA to TCTGGCA in the pAmBCD-SVLuc
construct, the induction ratio dropped to 1.6, indicating that OreB is
also required for full osmotic response. Among the three sequences, the
sequence of OreC was closest to the rabbit ORE and the canine TonE
sequence. When a single base substitution was made in OreC, changing
the core sequence from TGGAAAA to TAGAAAA in
the pABmCD-SVLuc construct, the induction ratio dropped to 0.6, indicating that OreC is the key component of the osmotic response
region. However, with fragment C alone, the induction ratio was only
0.9. Therefore, OreC alone is not sufficient to induce transcription
under hyperosmotic stress. Similarly, fragment AB alone also did not
respond to hyperosmotic induction. These results suggest that the
osmotic response region in human AR consists of at least three
TonE-like sequences. Each of these sequences alone is unable to induce
transcription.
Interaction of Osmotic Response Region and Transcription
Factors
To see if the sequence within the putative osmotic
response region interacts with transcription factors, we performed gel mobility shift assay using the 132-bp fragment ( 1235 to 1104) as a
probe. As shown in Fig. 5, two prominent bands were
observed when the probe was incubated with nuclear extracts from Chang liver cells exposed to hyperosmotic medium (lane 3),
suggesting that there may be two different types of DNA/protein
interaction. Nuclear extracts from Chang liver cells maintained in
isosmotic medium resulted in a similar banding pattern, but a much
weaker signal (lanes 2 and 4). These bands could
be competed out by the addition of excess unlabeled 132-bp DNA
(lanes 4-6 and 7-9), indicating the specificity
of the DNA/protein interaction. These results suggest that Chang liver
cells cultured in isosmotic medium express a very low level of
transcription factor(s), whose expression is highly induced when cells
are incubated in hyperosmotic medium. Alternatively, in isosmotic
medium, an inactive form of the transcription factor(s) is made, and it
is activated in response to hyperosmotic stress.
Fig. 5.
Gel mobility shift and competition assays of
the osmotic response region. Four micrograms of nuclear extracts,
from Chang liver cells maintained in hyperosmotic (H) or
isosmotic (I) medium, was incubated with the
32P-labeled 132-bp DNA fragment in the absence ( ) or
presence of 10- and 50-fold molar excesses of the unlabeled 132-bp DNA
fragment.
[View Larger Version of this Image (94K GIF file)]
DISCUSSION
The induction of aldose reductase or aldose reductase mRNA by
hyperosmolality has been demonstrated in a variety of cells. These
include a cell line derived from rabbit renal papillae (15, 16), human
renal proximal tubule cells (27), Chinese hamster ovary cells (26), a
lens epithelial cell line from a transgenic mouse (32), human retinal
pigment epithelial cells (28), human embryonic epithelial cells (33),
and, in our study, Chang liver cells. Therefore, it appears that
hyperosmotic induction of AR is not unique to renal medullary cells,
which are constantly exposed to extreme hyperosmolality. Many other
cells also employ this protective response when they are exposed to
hyperosmotic stress.
Aldose reductase and the betaine, myo-inositol, and taurine
transporters represent a class of protein that is induced by
hyperosmotic stress (18). At this point, how the transcription of these
genes is regulated and whether they share some common transcription factors are not known. During the preparation of this report, the ORE
of the rabbit AR gene was identified (20). This 11-bp element shares
sequence homology with TonE of the canine betaine transporter gene. We
found that within the 132-bp fragment that contains the osmotic
response region of human AR, there are three sequences that resemble
these osmotic response elements, indicating that osmotic regulation of
gene expression is probably similar in different mammals. The three
sequences within the 132-bp fragment of human AR have to be present
together for efficient induction of transcription. It is likely that a
similar situation occurs in the rabbit AR gene, where a single
independently active ORE has been identified. However, the osmotic
induction ratio is reduced from 9.4 to 2.0 when the sequence is reduced
from 3221 to 11 bp, and the authors suggest the possibility that other
cis-elements may potentiate the osmotic response. A similar
gradual reduction in the induction ratio upon shortening of test
fragments containing TonE was also observed in the canine betaine
transporter gene (19). Interestingly, the concatemer of TonE of this
gene and the concatemer of the ORE of the rabbit AR gene induced
transcription to a much higher level than a single element. Among the
three putative OREs that we identified, OreC is most similar to TonE and to the rabbit AR ORE, and it contributes the most to the osmotic induction of transcription. Yet, even this element, when fused to the
reporter gene alone, did not induce transcription to any significant
level. The TonE element is functional in both orientations. We found
that OreB, located between OreA and OreC, is in the opposite orientation to these two sequences. This further supports the idea that
these putative enhancer elements are functional in both orientations.
Regulation of gene expression in response to hyperosmolality was better
studied in Escherichia coli. In response to hyperosmotic stress, there is an increase in the expression of the Pro-U operon, which encodes a high affinity betaine transporter (34). A DNA-binding protein (H-NS) acts as a transcriptional repressor of the Pro-U operon
under isosmotic conditions. The inhibitory effect of H-NS is relieved
by extracellular hyperosmolality, resulting in transcription of the
operon (35). The regulation of AR by hyperosmolality is quite different
from that of the Pro-U operon of E. coli because the results
of the gel mobility shift assays (Fig. 5) showed that there is an
increase in the transcription factor(s) binding to the putative ORE
under hyperosmotic conditions. It is interesting that using the 132-bp
fragment as a probe, gel mobility shift assay generated two bands.
Although our transfection assays showed that all three putative OREs
within this 132-bp fragment are necessary for osmotic response, it is
possible that, under our in vitro conditions, one or more of
the putative OREs are occupied by transcription factors, resulting in
two different types of protein-DNA complex. Alternatively, it is
possible that this reflects interactions between OREs. The slower
migrating band may contain aggregates of protein-DNA complexes
generated through protein/protein interaction.
Although hyperosmolality also activates immediate-early genes like
egr-1 and c-fos (36) and genes in the signal
transduction pathway such as jnk (37), phospholipase C,
Raf-1 kinase, mitogen-activated protein kinase kinase, and
mitogen-activated protein kinase (38, 39), there is still little
information available regarding the mechanism by which the signal of
hyperosmolality mediates gene expression. Identification of the
trans-acting factors that interact with the osmotic response
region may help us elucidate this osmolality signal transduction
pathway of gene regulation.
FOOTNOTES
*
This work was supported by Research Grant Council Grant
HKU262/92M, Committee on Research and Conference Grant 335/089/0001, National Institutes of Health Grant EY11018 (to K. H. G.), grants from the Juvenile Diabetes Foundation (to K. H. G. and K. M B.), and funds from the Harry B. and Aileen B. Gordon Foundation (to K. H. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U72619[GenBank].
¶
To whom correspondence and reprint requests should be
addressed. Tel.: 852-28168428; Fax: 852-28171006; E-mail:
smchung{at}hkucc.hku.hk.
1
The abbreviations used are: AR, aldose
reductase; bp, base pair(s); kb, kilobase pair(s); ORE, osmotic
response element.
ACKNOWLEDGEMENTS
We thank Dr. Amy Lo and K. Chan for helpful
comments on the manuscript, Dr. D. L. Cao for help in the preparation
of RNA, Anthony Chan for help in automated sequencing, and Dr. S. K. Chung for helpful discussions.
REFERENCES
-
Garcia-Perez, A., and Burg, M. B.
(1991)
Physiol. Rev.
71,
1081-1115
[Abstract/Free Full Text]
-
Yancey, P. H., Clark, M. E., Hand, S. C., Bowlus, R. D., and Somero, G. N.
(1982)
Science
217,
1214-1222
[Abstract/Free Full Text]
-
Gullans, S. R., Blumenfeld, J. D., Balschi, J. A., Kaleta, M., Brenner, R. M., Heilig, C. W., and Hebert, S. C.
(1988)
Am. J. Physiol.
255,
F626-F634
[Abstract/Free Full Text]
-
Bagnasco, S., Balaban, R., Fales, H. M., Yang, Y.-M., and Burg, M.
(1986)
J. Biol. Chem.
261,
5872-5877
[Abstract/Free Full Text]
-
Ohta, M., Tanimoto, T., and Tanaka, A.
(1991)
Biochim. Biophys. Acta
1078,
395-403
[CrossRef][Medline]
[Order article via Infotrieve]
-
Petrash, J. M., and Srivastava, S. K.
(1982)
Biochim. Biophys. Acta
707,
105-114
[CrossRef][Medline]
[Order article via Infotrieve]
-
Srivastava, S. K., Goldblum, R. M., Hair, G. A., and Das, B.
(1984)
Lens Res.
2,
309-320
-
Das, B., and Srivastava, S. K.
(1985)
Biochim. Biophys. Acta
238,
670-679
-
Lee, A. Y., Chung, S. K., and Chung, S. S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2780-2784
[Abstract/Free Full Text]
-
Kador, P. F., and Kinoshita, J. H. (1985) Am. J. Med.
79, Suppl. 5A, 8-12
-
Greene, D. A., Lattimer, S., Ulbrecht, J., and Carroll, P.
(1985)
Diabetes Care
8,
290-299
[Abstract]
-
Burg, M. B.
(1988)
Kidney Int.
33,
635-641
[Medline]
[Order article via Infotrieve]
-
King, T. F., and Mann, T.
(1959)
Proc. R. Soc. Lond. B Biol. Sci.
151,
226
[Abstract/Free Full Text]
-
Cowley, B. D., Ferraris, J. D., Jr., Carper, D., and Burg, M.
(1990)
Am. J. Physiol.
258,
F154-F161
[Abstract/Free Full Text]
-
Smardo, F. L., Burg, M. B., Jr., and Garcia-Perez, A.
(1992)
Am. J. Physiol.
262,
C776-C782
[Abstract/Free Full Text]
-
Garcia-Perez, A., Martin, B., Murphy, H. R., Uchida, S., Murer, H., Cowley, B. D., Jr., Handler, J. S., and Burg, M. B.
(1989)
J. Biol. Chem.
264,
16815-16821
[Abstract/Free Full Text]
-
Uchida, S., Garcia-Perez, A., Murphy, H., and Burg, M.
(1989)
Am. J. Physiol.
256,
C614-C620
[Abstract/Free Full Text]
-
Burg, M.
(1995)
Am. J. Physiol.
268,
F983-F996
[Abstract/Free Full Text]
-
Takenaka, M., Preston, A. S., Kwon, H. M., and Handler, J. S.
(1994)
J. Biol. Chem.
269,
29379-29381
[Abstract/Free Full Text]
-
Ferraris, J. D., Williams, C. K., Jung, K. Y., Bedford, J. J., Burg, M. B., and Garcia-Perez, A.
(1996)
J. Biol. Chem.
271,
18318-18321
[Abstract/Free Full Text]
-
Ruepp, B., Bohren, K. M., and Gabbay, K. H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
8624-8629
[Abstract/Free Full Text]
-
Auffray, C., and Rougeon, F.
(1980)
Eur. J. Biochem.
107,
303-314
[Medline]
[Order article via Infotrieve]
-
Chung, S., and LaMendola, J.
(1989)
J. Biol. Chem.
264,
14775-14777
[Abstract/Free Full Text]
-
Ko, B. C. B., Lam, K. S. L., Wat, N. M. S., and Chung, S. S. M.
(1995)
Diabetes
44,
727-732
[Abstract]
-
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K.
(eds)
(1996)
Current Protocols in Molecular Biology, Vol. 1, p. 1.7.6, John Wiley & Sons, Inc., New York
-
Kaneko, M., Carper, D., Nishimura, C., Millen, J., Bock, M., and Hohman, T. C.
(1990)
Exp. Cell Res.
188,
135-140
[CrossRef][Medline]
[Order article via Infotrieve]
-
Petrash, J. M., Flath, M., Sens, D., and Bylander, J.
(1992)
Biochem. Biophys. Res. Commun.
187,
201-208
[CrossRef][Medline]
[Order article via Infotrieve]
-
Stevens, M. J., Henry, D. N., Thomas, T. P., Killen, P. D., and Greene, D. A.
(1993)
Am. J. Physiol.
265,
E428-E438
[Abstract/Free Full Text]
-
Wang, K., Bohren, K. M., and Gabbay, K. H.
(1993)
J. Biol. Chem.
268,
16052-16058
[Abstract/Free Full Text]
-
Graham, A. G., Brown, L., Hedge, P. J., Gammack, A. J., and Markham, A. F.
(1991)
J. Biol. Chem.
266,
6872-6877
[Abstract/Free Full Text]
-
Ferraris, J. D., Williams, C. K., Martin, B. M., Burg, M. B., and Gracia-Perez, A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10742-10746
[Abstract/Free Full Text]
-
Russell, P., Yamada, T., and Merola, L. O.
(1990)
Arch. Biochem. Biophys.
276,
259-264
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ferraretto, A., Negri, A., Giuliani, A., Grada, L. D., Conti, A. M. F., and Ronchi, S.
(1993)
Biochim. Biophys. Acta
1175,
283-288
[Medline]
[Order article via Infotrieve]
-
Cairney, J., Booth, I. R., and Higgins, C. F.
(1985)
J. Bacteriol.
164,
1224-1232
[Abstract/Free Full Text]
-
Ueguchi, C., and Mizuno, T.
(1993)
EMBO J.
12,
1039-1046
[Medline]
[Order article via Infotrieve]
-
Cohen, D. M., Wasserman, J. C., and Gullans, S. R.
(1991)
Am. J. Physiol.
261,
C594-C601
[Abstract/Free Full Text]
-
Galcheva-Gargova, Z., Derijard, B., Wu, I. H., and Davis, R. J.
(1994)
Science
265,
806-808
[Abstract/Free Full Text]
-
Terada, Y., Tomita, K., Homma, M. K., Nonoguchi, H., Yang, T., Yamada, T., Yuasa, Y., Krebs, E. G., Sasaki, S., and Marumo, F.
(1994)
J. Biol. Chem.
269,
31296-31301
[Abstract/Free Full Text]
-
Itoh, T., Yamauchi, A., Miyai, A., Yokoyama, K., Kamada, T., Ueda, N., and Fujiwara, Y.
(1994)
J. Clin. Invest.
93,
2387-2392
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Kuper, D. Steinert, M.-L. Fraek, F.-X. Beck, and W. Neuhofer
EGF receptor signaling is involved in expression of osmoprotective TonEBP target gene aldose reductase under hypertonic conditions
Am J Physiol Renal Physiol,
May 1, 2009;
296(5):
F1100 - F1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler
Controlled aquaporin-2 expression in the hypertonic environment
Am J Physiol Cell Physiol,
April 1, 2009;
296(4):
C641 - C653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen
Physiology of Cell Volume Regulation in Vertebrates
Physiol Rev,
January 1, 2009;
89(1):
193 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rodgaard, K. Schou, M. B. Friis, and E. K. Hoffmann
Does the intracellular ionic concentration or the cell water content (cell volume) determine the activity of TonEBP in NIH3T3 cells?
Am J Physiol Cell Physiol,
December 1, 2008;
295(6):
C1528 - C1534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Xu, C. C. L. Wong, E. H. Y. Tong, S. S. M. Chung, J. R. Yates III, Y. Yin, and B. C. B. Ko
Phosphorylation by Casein Kinase 1 Regulates Tonicity-induced Osmotic Response Element-binding Protein/Tonicity Enhancer-binding Protein Nucleocytoplasmic Trafficking
J. Biol. Chem.,
June 20, 2008;
283(25):
17624 - 17634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Irarrazabal, C. K. Williams, M. A. Ely, M. J. Birrer, A. Garcia-Perez, M. B. Burg, and J. D. Ferraris
Activator Protein-1 Contributes to High NaCl-induced Increase in Tonicity-responsive Enhancer/Osmotic Response Element-binding Protein Transactivating Activity
J. Biol. Chem.,
February 1, 2008;
283(5):
2554 - 2563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva
Cellular Response to Hyperosmotic Stresses
Physiol Rev,
October 1, 2007;
87(4):
1441 - 1474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kosuge, A. I. Chuang, S. Uematsu, K. P. Tan, K. Ohashi, B. C.B. Ko, and S. Ito
Discovery of Osmosensitive Transcriptional Regulation of Human Cytochrome P450 3As by the Tonicity-Responsive Enhancer Binding Protein (Nuclear Factor of Activated T Cells 5)
Mol. Pharmacol.,
October 1, 2007;
72(4):
826 - 837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Padda, A. Wamsley-Davis, M. C. Gustin, R. Ross, C. Yu, and D. Sheikh-Hamad
MEKK3-mediated signaling to p38 kinase and TonE in hypertonically stressed kidney cells
Am J Physiol Renal Physiol,
October 1, 2006;
291(4):
F874 - F881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-T. Tsai, K. G. Danielson, A. Guttapalli, E. Oguz, T. J. Albert, I. M. Shapiro, and M. V. Risbud
TonEBP/OREBP Is a Regulator of Nucleus Pulposus Cell Function and Survival in the Intervertebral Disc
J. Biol. Chem.,
September 1, 2006;
281(35):
25416 - 25424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Y. Tong, J.-J. Guo, A.-L. Huang, H. Liu, C.-D. Hu, S. S. M. Chung, and B. C. B. Ko
Regulation of Nucleocytoplasmic Trafficking of Transcription Factor OREBP/TonEBP/NFAT5
J. Biol. Chem.,
August 18, 2006;
281(33):
23870 - 23879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler, U. S. Jeon, J. A. Kim, D. Mordasini, H. M. Kwon, E. Feraille, and P.-Y. Martin
Tonicity-Responsive Enhancer Binding Protein Is an Essential Regulator of Aquaporin-2 Expression in Renal Collecting Duct Principal Cells
J. Am. Soc. Nephrol.,
June 1, 2006;
17(6):
1521 - 1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Yang, A. D. Hodgkinson, P. J. Oates, H. M. Kwon, B. A. Millward, and A. G. Demaine
Elevated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy.
Diabetes,
May 1, 2006;
55(5):
1450 - 1455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler, M. Vinciguerra, A. Vandewalle, P.-Y. Martin, and E. Feraille
Dual Effects of Hypertonicity on Aquaporin-2 Expression in Cultured Renal Collecting Duct Principal Cells
J. Am. Soc. Nephrol.,
June 1, 2005;
16(6):
1571 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Prabhu, R. J. Arner, H. Vunta, and C. C. Reddy
Up-regulation of Human myo-Inositol Oxygenase by Hyperosmotic Stress in Renal Proximal Tubular Epithelial Cells
J. Biol. Chem.,
May 20, 2005;
280(20):
19895 - 19901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, B. C. B. Ko, J. Y. Yang, T. T. L. Lam, Z. Jiang, J. Zhang, S. K. Chung, and S. S. M. Chung
Transgenic Mice Expressing Dominant-negative Osmotic-response Element-binding Protein (OREBP) in Lens Exhibit Fiber Cell Elongation Defect Associated with Increased DNA Breaks
J. Biol. Chem.,
May 20, 2005;
280(20):
19986 - 19991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jauniaux, J. Hempstock, C. Teng, F. C. Battaglia, and G. J. Burton
Polyol Concentrations in the Fluid Compartments of the Human Conceptus during the First Trimester of Pregnancy: Maintenance of Redox Potential in a Low Oxygen Environment
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
1171 - 1175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lopez-Rodriguez, C. L. Antos, J. M. Shelton, J. A. Richardson, F. Lin, T. I. Novobrantseva, R. T. Bronson, P. Igarashi, A. Rao, and E. N. Olson
Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression
PNAS,
February 24, 2004;
101(8):
2392 - 2397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. B. Ko, A. K. M. Lam, A. Kapus, L. Fan, S. K. Chung, and S. S. M. Chung
Fyn and p38 Signaling Are Both Required for Maximal Hypertonic Activation of the Osmotic Response Element-binding Protein/Tonicity-responsive Enhancer-binding Protein (OREBP/TonEBP)
J. Biol. Chem.,
November 22, 2002;
277(48):
46085 - 46092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Trama, W. Y. Go, and S. N. Ho
The Osmoprotective Function of the NFAT5 Transcription Factor in T Cell Development and Activation
J. Immunol.,
November 15, 2002;
169(10):
5477 - 5488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Jung, Y.-H. Kim, J.-H. Cha, K.-H. Han, M.-K. Kim, K. M. Madsen, and J. Kim
Expression of aldose reductase in developing rat kidney
Am J Physiol Renal Physiol,
September 1, 2002;
283(3):
F481 - F491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Woo, S. D. Lee, K. Y. Na, W. K. Park, and H. M. Kwon
TonEBP/NFAT5 Stimulates Transcription of HSP70 in Response to Hypertonicity
Mol. Cell. Biol.,
August 15, 2002;
22(16):
5753 - 5760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sheikh-Hamad, V. Nadkarni, Y.-J. Choi, L. D. Truong, C. Wideman, R. Hodjati, and K. H. Gabbay
Cyclosporine A Inhibits the Adaptive Responses to Hypertonicity: A Potential Mechanism of Nephrotoxicity
J. Am. Soc. Nephrol.,
December 1, 2001;
12(12):
2732 - 2741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. CHA, S. K. WOO, K. H. HAN, Y. H. KIM, J. S. HANDLER, J. KIM, and H. M. KWON
Hydration Status Affects Nuclear Distribution of Transcription Factor Tonicity Responsive Enhancer Binding Protein in Rat Kidney
J. Am. Soc. Nephrol.,
November 1, 2001;
12(11):
2221 - 2230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Ferraris and A. Garcia-Perez
Osmotically Responsive Genes: The Mammalian Osmotic Response Element (ORE)
Integr. Comp. Biol.,
August 1, 2001;
41(4):
734 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsuzaki, T. Suzuki, and K. Takata
Hypertonicity-induced expression of aquaporin 3 in MDCK cells
Am J Physiol Cell Physiol,
July 1, 2001;
281(1):
C55 - C63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Dahl, J. S. Handler, and H. M. Kwon
Hypertonicity-induced phosphorylation and nuclear localization of the transcription factor TonEBP
Am J Physiol Cell Physiol,
February 1, 2001;
280(2):
C248 - C253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Demaine, D. Cross, and A. Millward
Polymorphisms of the Aldose Reductase Gene and Susceptibility to Retinopathy in Type 1 Diabetes Mellitus
Invest. Ophthalmol. Vis. Sci.,
December 1, 2000;
41(13):
4064 - 4068.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. T. B. Ho, S. K. Chung, J. W. S. Law, B. C. B. Ko, S. C. F. Tam, H. L. Brooks, M. A. Knepper, and S. S. M. Chung
Aldose Reductase-Deficient Mice Develop Nephrogenic Diabetes Insipidus
Mol. Cell. Biol.,
August 15, 2000;
20(16):
5840 - 5846.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. K. Woo, S. C. Dahl, J. S. Handler, and H. M. Kwon
Bidirectional regulation of tonicity-responsive enhancer binding protein in response to changes in tonicity
Am J Physiol Renal Physiol,
June 1, 2000;
278(6):
F1006 - F1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Woo, D. Maouyo, J. S. Handler, and H. M. Kwon
Nuclear redistribution of tonicity-responsive enhancer binding protein requires proteasome activity
Am J Physiol Cell Physiol,
February 1, 2000;
278(2):
C323 - C330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bai, J. F. Collins, Y. L. Muller, H. Xu, P. R. Kiela, and F. K. Ghishan
Characterization of cis-elements required for osmotic response of rat Na+/H+ exchanger-2 (NHE-2) gene
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 1999;
277(4):
R1112 - R1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Nadkarni, K. H. Gabbay, K. M. Bohren, and D. Sheikh-Hamad
Osmotic Response Element Enhancer Activity. REGULATION THROUGH p38 KINASE AND MITOGEN-ACTIVATED EXTRACELLULAR SIGNAL-REGULATED KINASE KINASE
J. Biol. Chem.,
July 16, 1999;
274(29):
20185 - 20190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Henry, J. V. Busik, F. C. Brosius III, and C. W. Heilig
Glucose transporters control gene expression of aldose reductase, PKCalpha , and GLUT1 in mesangial cells in vitro
Am J Physiol Renal Physiol,
July 1, 1999;
277(1):
F97 - F104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Iwata, S. Sato, J. Jimenez, M. McGowan, M. Moroni, A. Dey, N. Ibaraki, V. N. Reddy, and D. Carper
Osmotic Response Element Is Required for the Induction of Aldose Reductase by Tumor Necrosis Factor-alpha
J. Biol. Chem.,
March 19, 1999;
274(12):
7993 - 8001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Miyakawa, S. K. Woo, S. C. Dahl, J. S. Handler, and H. M. Kwon
Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity
PNAS,
March 2, 1999;
96(5):
2538 - 2542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Ferraris, C. K. Williams, A. Ohtaka, and A. Garcia-Perez
Functional consensus for mammalian osmotic response elements
Am J Physiol Cell Physiol,
March 1, 1999;
276(3):
C667 - C673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aida, M. Tawata, Y. Ikegishi, and T. Onaya
Induction of Rat Aldose Reductase Gene Transcription Is Mediated through the cis-Element, Osmotic Response Element (ORE): Increased Synthesis and/or Activation by Phosphorylation of ORE-Binding Protein Is a Key Step
Endocrinology,
February 1, 1999;
140(2):
609 - 617.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. S. Rim, M. G. Atta, S. C. Dahl, G. T. Berry, J. S. Handler, and H. M. Kwon
Transcription of the Sodium/myo-Inositol Cotransporter Gene Is Regulated by Multiple Tonicity-responsive Enhancers Spread over 50 Kilobase Pairs in the 5'-Flanking Region
J. Biol. Chem.,
August 7, 1998;
273(32):
20615 - 20621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Miyakawa, S. K. Woo, C.-P. Chen, S. C. Dahl, J. S. Handler, and H. M. Kwon
Cis- and trans-acting factors regulating transcription of the BGT1 gene in response to hypertonicity
Am J Physiol Renal Physiol,
April 1, 1998;
274(4):
F753 - F761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Yabe-Nishimura
Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications
Pharmacol. Rev.,
March 1, 1998;
50(1):
21 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E Heesom, A. Millward, and A. G Demaine
Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene
J. Neurol. Neurosurg. Psychiatry,
February 1, 1998;
64(2):
213 - 216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Iwata, S. Minucci, M. McGowan, and D. Carper
Identification of a Novel cis-Element Required for the Constitutive Activity and Osmotic Response of the Rat Aldose Reductase Promoter
J. Biol. Chem.,
December 19, 1997;
272(51):
32500 - 32506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Venkatesh, S. L. Si-Hoe, D. Murphy, and S. Brenner
Transgenic rats reveal functional conservation of regulatory controls between the Fugu isotocin and rat oxytocin genes
PNAS,
November 11, 1997;
94(23):
12462 - 12466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Nahm, S. K. Woo, J. S. Handler, and H. M. Kwon
Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity
Am J Physiol Cell Physiol,
January 1, 2002;
282(1):
C49 - C58.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|